Navigation Links
Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
Date:9/12/2007

TORONTO, Sept. 12 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH, NASDAQ:TTHI) a product-focused biopharmaceutical company developing therapeutics for disease indications with large markets, today announced its financial results for the year ended June 30, 2007.

Selected Highlights

-------------------

During fiscal 2007 and up to the date of this press release, the Company achieved the following significant milestones:

ELND005/AZD-103 - Alzheimer's Disease:

--------------------------------------

- Clinical Data Results: On August 30, 2007, the Company Announced

Completion of Multiple Phase I Clinical Studies with Alzheimer's

Disease Drug Candidate ELND-005/AZD-103. ELND-005/AZD-103 was safe

and well-tolerated at all doses and dosing regimens examined. There

were no severe or serious adverse events observed. ELND-005/AZD-103

was also shown to be orally bio-available, cross the blood-brain

barrier and achieve levels in the human brain and CSF that were shown

to be effective in animal models for Alzheimer's disease.

- FDA Granted Fast Track Designation for Alzheimer's Disease Drug

Candidate ELND-005/AZD-103 which is being developed in collaboration

with Elan Pharma International Limited ("Elan") for the treatment of

Alzheimer's disease.

- Transition and Elan signed a US$200 million global collaboration

agreement to develop and commercialize the Alzheimer's disease

product, ELND-005/AZD-103. Under the terms of the agreement,

Transition has received an upfront payment of US$7.5 million and will

receive an additional upfront payment of US$7.5 million in calendar

2007. Dependent upon the successful development, regulatory and

commercial launch of ELND-005/AZD-103, Transition will be eligible to

rec
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Mans Transition from Foragers to Agriculturalist Led to Increase in Birth Rates
2. Rocky Transition to the Medicare Drug Program
3. Customized Post Operation Care Offers Patients a Smooth Transition to Patients into the Community
4. Mental Health - NHS Trust Commences Specialist Transition Service
5. Permanent Weight Loss Requires Transition to Healthy Eating
6. VBI Provides Potential Targets to Diabetes Therapeutics
7. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
8. PM announces a new health care order for India
9. Ramdoss Announces Introduction of RCH-II
10. Britain Announces Third Transfusion Related Mad Cow Case
11. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...icular cancer who were treated with cisplatin-base...ding neurological side effects and Raynaud-like ph...herapy, according to a new study published online ... Institute . , Marianne Brydy, M.D., of the Depa... in Bergen, Norway, and colleagues conducted a cro...
(Date:11/25/2009)...at grew out of a collaboration between UCLA engine... the nearly 10 million Americans who suffer from p...hardening of the arteries, peripheral arterial dis...hich narrowed arteries reduce blood flow to the li...scular disease, heart attack and stroke, and its p...
(Date:11/25/2009)...s too short to draw definite conclusions, experts ...News) -- In diabetic patients with blocked coronar...utcomes at one year whether patients undergo bypas...searchers report. , Bypass surgery has been the...onary artery disease. However, less invasive appro...
(Date:11/25/2009)...luation and treatment clinics to resume Monday, No... November 25, 2009 -- Centegra Health System is co...cine shots at four Centegra Primary Care (CPC) vac... has arrived. The clinics are at CPC sites in Hunt...be open as follows: ,   From 4:30 to 7...
(Date:11/25/2009)...urological symptoms, study finds , , WE...side effects are among the potential problems face...were treated with cisplatin-based chemotherapy, a ... Norwegian men treated for unilateral testicular c...low-up survey conducted from 1998 to 2002. , Th...
Breaking Medicine News(10 mins):Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...shington – Today, the nursing profession is sought...reign countries has made the noble profession,// l...to foreign lands, in search of greener pastures. T...omeland to find work in the Unites States. In the ...
... a tragic mistake, the young life of John Mealey, ... infection for a simple// hangover. Describin... centre for excellence for this very type of condi...y was admitted to Aintree Hospitals NHS Trust - a ...
...w Haven, Conn. — Recurring chlamydia infections ar...o a Yale Department of Epidemiology and Public Hea...istant professor in the division of Epidemiology o...osed with chlamydia and then, in a rate higher tha...
...tamin A deficiency has resulted in blindness among...of India, a study has found.// As much as 51... blind in that region have become blind over a per...the North East, a study reveals. There is a sing...
...top drug regulator told lawmakers Monday it could ... safely approve generic versions of biotech drugs ...ditional drugs. Food and Drug Administration d... in the U.S. for their products, some of the most ...
...premier Indian medical institution failed to infor...positive. The girl paid for its callousness//, wit...channel. 17-year-old Jyoti, was the daughter of ...Medical Sciences (AIIMS), a prestigious institutio...
Other Medicine News:Health News:‘Drunk’ Doctors Misdiagnosis Proves Fat 2Health News:Recurring Chlamydia Infections Common in Teenage Girls 2Health News:FDA Cites Challenges of Generic Biotech 2Health News:Patient Pays For The Callousness Of Hospital Administration 2
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker.com...itscatalogue: ,, UnitedStatesDentalDevicesMark...portlinker.com/p0158733/United-States-Dental-Devic..., UnitedStatesDentalDevicesMarketAnalysisandForec...entialsourceforin-depthinformationanddatarelatingt...
(Date:11/25/2009)...,, SANDIEGO,Nov.25/PRNewswire-FirstCall/--NuVas...edondevelopingproductsforminimallydisruptivesurgic...staconferencecallonMonday,November30,2009,at5:30p....tissuesrelativetoreimbursementfortheCompany,sprodu...shortquestionandanswersession.Thedial-innumbersare...
(Date:11/25/2009)...,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewswire-...WR ;ASX:HIN),aleadinginnovatorandprovideroflessinv...volutionizingthetreatmentofadvancedheartfailure,to...ntationatthe21stAnnualPiperJaffrayHealthCareConfer...renceisbeingheldattheNewYorkPalaceHotel,December1-...
Breaking Medicine Technology:Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3Families With Special Needs Children Need Special Financial Strategies 53581 1Families With Special Needs Children Need Special Financial Strategies 53581 2Families With Special Needs Children Need Special Financial Strategies 53581 3Sustainable agriculture at the ESA Annual Meeting 9466 1Sustainable agriculture at the ESA Annual Meeting 9466 2Sustainable agriculture at the ESA Annual Meeting 9466 3Sustainable agriculture at the ESA Annual Meeting 9466 4FDA selects Sensotech 26apos 3Bs Wireless Temperature Monitoring System 53576 1FDA selects Sensotech 26apos 3Bs Wireless Temperature Monitoring System 53576 2
...Hit Therapeutics,(Alternext: ALEHT) is pleased to ...d compound in Alzheimer,s disease, is progressing ...sessing EHT 0202 in patients with,Alzheimer,s dise... of patient enrolment for the Phase IIa,represents...0202, and,provides a clear timeline for the releas...
...o long for surgery, study finds , , LAS VEGAS, Fe... to have poorer joint function before undergoing h... study presented today at the 2009 Annual Meeting ...(AAOS) ( http://www.aaos.org/ ). In addition, fema...than male patients across ethnic groups. , , "Stu...
Other Medicine Technology:ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4When to Have That Joint Replacement? 2When to Have That Joint Replacement? 3
O-arm Complete Multidimensional Surgical Imaging
ABX Micros IM Hematology Analyzers
Rio™ Aspiration Catheter
Sound Pro Combination Table
Medicine Products: